JD vs POM
JD.com, Inc. and Pomdoctor Limited, side by side — 3 fiscal years reported in CNY, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | JD | POM |
|---|---|---|
| Revenue | ¥1.3T | ¥399.9M |
| Net income | ¥23.1B | ¥-130.9M |
| Gross margin | 16.0% | 13.1% |
| Net margin | 1.8% | −32.7% |
| Return on equity | 10.0% | — |
| Diluted EPS | — | −¥21.96 |
| Dividend / share | — | — |
| Payout ratio | 44.8% | — |
| Free cash flow | ¥11.2B | ¥-149.5M |
| Equity | ¥225.0B | ¥-454.0M |
| Net debt / equity | −0.41× | — |
| Current ratio | 1.22× | 0.48× |
| Revenue CAGR 5y | 11.9% | — |
| Profit CAGR 5y | −14.1% | — |
JD bills 3273.4× the revenue of POM, and POM closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
3 years side by side
| Fiscal year | JD | POM |
|---|---|---|
| FY2025 | ¥1.3T | ¥399.9M |
| FY2024 | ¥1.2T | ¥342.6M |
| FY2023 | ¥1.1T | ¥304.9M |
Net income by year
Bottom line
| Fiscal year | JD | POM |
|---|---|---|
| FY2025 | ¥23.1B | ¥-130.9M |
| FY2024 | ¥44.7B | ¥-37.4M |
| FY2023 | ¥23.3B | ¥-36.9M |
Advertisement
AdSense · Rectangle 336×280
More in this industry